DUSA PHARMACEUTICALS, INC.
NASDAQ : DUSA

DUSA PHARMACEUTICALS, INC.

July 12, 2005 08:00 ET

DUSA Pharmaceuticals, Inc. to Host Conference Call Re Second Quarter 2005 Levulan'R' Kerastick'R' and BLU-U'R' Sales Update

WILMINGTON, MASSACHUSETTS--(CCNMatthews - July 12, 2005) - DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA) announces that an update regarding second quarter Levulan Kerastick and BLU-U end user sales will be issued after the close on Thursday July 14, 2005, to be followed by a conference call at 8:45 a.m. Friday, July 15, 2005,



Friday, July 15, 8:45 a.m. Eastern
If calling from the US or Canada use the following toll-free number:
800.936.4602
Password - DUSA

For International callers use
507.726.3418
Password - DUSA

You will also be able to listen to a replay of the conference call
using the following numbers:
North American callers 800.334.2128
International callers 580.431.2986


The call will be accessible on our web site after the call at www.dusapharma.com.

DUSA Pharmaceuticals, Inc. is a biopharmaceutical company engaged primarily in the development of Levulan® Photodynamic Therapy (PDT) and Photodetection (PD) for multiple medical conditions, with its primary focus in dermatology. PDT and PD utilize light-activated compounds to induce a therapeutic or detection effect. DUSA maintains offices in Wilmington, MA, Valhalla, NY and Toronto, Ontario.

Contact Information

  • DUSA Pharmaceuticals, Inc.
    Shari Lovell
    Director, Shareholder Services
    (416) 363-5059
    (416) 363-6602 (FAX)
    www.dusapharma.com